Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
Dec 24, 2020 $1.50 $1.56 $1.47 $1.52 92 116
Dec 23, 2020 $1.47 $1.55 $1.40 $1.51 237 143
Dec 22, 2020 $1.48 $1.50 $1.43 $1.46 130 858
Dec 21, 2020 $1.49 $1.50 $1.42 $1.44 149 969
Dec 18, 2020 $1.47 $1.55 $1.46 $1.48 180 769
Dec 17, 2020 $1.47 $1.53 $1.47 $1.48 112 035
Dec 16, 2020 $1.47 $1.54 $1.44 $1.49 201 487
Dec 15, 2020 $1.40 $1.47 $1.37 $1.46 254 995
Dec 14, 2020 $1.29 $1.48 $1.25 $1.45 1 535 038
Dec 11, 2020 $1.65 $1.70 $1.60 $1.64 156 600
Dec 10, 2020 $1.54 $1.65 $1.48 $1.65 226 242
Dec 09, 2020 $1.60 $1.60 $1.46 $1.54 260 301
Dec 08, 2020 $1.60 $1.65 $1.57 $1.60 168 263
Dec 07, 2020 $1.63 $1.65 $1.56 $1.58 162 313
Dec 04, 2020 $1.63 $1.66 $1.59 $1.63 170 741
Dec 03, 2020 $1.75 $1.75 $1.58 $1.59 241 003
Dec 02, 2020 $1.51 $1.74 $1.49 $1.73 450 717
Dec 01, 2020 $1.50 $1.54 $1.50 $1.50 148 586
Nov 30, 2020 $1.46 $1.55 $1.44 $1.52 298 627
Nov 27, 2020 $1.45 $1.50 $1.43 $1.49 117 383
Nov 25, 2020 $1.44 $1.48 $1.43 $1.45 178 841
Nov 24, 2020 $1.47 $1.48 $1.43 $1.44 120 874
Nov 23, 2020 $1.48 $1.50 $1.41 $1.48 197 516
Nov 20, 2020 $1.35 $1.45 $1.32 $1.45 159 720
Nov 19, 2020 $1.46 $1.46 $1.37 $1.39 215 339
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT